Inventiva announces the randomization of the first patient i

Inventiva announces the randomization of the first patient in China in the NATiV3 clinical trial and provides an update on its clinical development program

Inventiva announces the randomization of the first patient in China in the NATiV3 clinical trial and provides an update on its clinical development program

finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.

Related Keywords

Israel , China , Mexico , Tianqing , Zhejiang , Russia , United States , New York , Ukraine , America , Pascaline Clerc , Aude Lepreux , Sino Biopharm , European Investment Bank , Chia Tai Tianqing Pharmaceutical Group Co Ltd , Corporate Affairs , European Union , Data Monitoring Committee , Company Nati , China National Medical Products Administration , Patricial Bank , Exchange Commission On , Drug Administration , Nasdaq , European Medicines Agency , Brunswick Group , National Medical Products Administration , Data Monitoring , Long Island City , Euronext Paris , Therapy Designation , Breakthrough Therapy Designation , Latin America , Breakthrough Therapy , Fast Track , Nasdaq Global Market , Roquet Montegon , Private Securities Litigation Reform Act , New Drug Application , Universal Registration Document , Des March , Annual Report , Exchange Commission , Half Year Report , Include Nonalcoholic Steatohepatitis , Patients With Type , Diabetes Care ,